About Tissue Diagnostics

Tissue diagnostics involves the diagnosis of diseases or analysis of the biological causes of the disease by extracting and analyzing a specific tissue. It has a broad range of applications in clinical research, clinical diagnostics, and cell biology. It is considered one of the most accurate techniques for the diagnosis of inflammatory conditions. Medical specialists particularly use tissue diagnostics in the area of molecular biology for cancer screening, therapy selection, diagnosis, and relapse monitoring. It helps in the screening and diagnosis of lymphoma, melanoma, leukemia, and breast, ovarian, cervical, head and neck, pancreatic, non-small cell lung, colorectal, brain, prostate, lung, and endometrial cancers. Pathologists use different technologies such as in situ hybridization (ISH), immunohistochemistry (IHC), special staining, and digital pathology and related methods including core biopsy, fine needle aspiration cytology, and open biopsy to study and diagnose cells.

Technavio’s analysts forecast the global tissue diagnostics market to grow at a CAGR of 11.59% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global tissue diagnostics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of diagnostic devices based on the following techniques:
• Advanced staining
• Preanalytical and routine staining
• Digital pathology

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio's report, Global Tissue Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Abbott Diagnostics
• Agilent Technologies (a parent company of Dako)
• Danaher (a parent company of Leica Biosystems)
• Roche Diagnostics

Other prominent vendors
• 20/20 GeneSystems
• Abcam
• AdnaGen
• Advanced Cell Diagnostics
• Affymetrix
• Agendia
• AutoGenomics
• AVIVA BioSciences
• Biocare Medical
• Biocartis
• Cancer Genetics
• ELITechGroup
• Enzo Biochem
• Epic Sciences
• Fluidigm
• HORIBA Medical
• Janssen Diagnostics
• Olympus Diagnostics Systems Group
• Omnyx (a joint venture of GE Healthcare and the University of Pittsburgh Medical Center, US)
• Oxford Gene Technology
• PANAGENE
• Protea Biosciences Group
• Sakura Finetek

Market driver
• Implementation by new customers
• For a full, detailed list, view our report

Market challenge
• Insurance coverage and reimbursement issues
• For a full, detailed list, view our report

Market trend
• Ready-to-use reagents
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.